HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yizhao Xie Selected Research

Chromatin

4/2023Chromatin Remodelling Molecule ARID1A Determines Metastatic Heterogeneity in Triple-Negative Breast Cancer by Competitively Binding to YAP.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Yizhao Xie Research Topics

Disease

24Breast Neoplasms (Breast Cancer)
09/2023 - 01/2018
12Neoplasms (Cancer)
09/2023 - 11/2016
7Neoplasm Metastasis (Metastasis)
01/2023 - 01/2019
6Triple Negative Breast Neoplasms
04/2023 - 10/2018
1Chronic Obstructive Pulmonary Disease (COPD)
01/2023
1Pneumonia (Pneumonitis)
01/2021
1Anemia
01/2021
1Leukemia
01/2021
1Leukopenia
01/2021
1Neutropenia
01/2021

Drug/Important Bio-Agent (IBA)

6Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link
09/2023 - 01/2018
5Estrogen ReceptorsIBA
01/2023 - 01/2018
5Fulvestrant (Faslodex)FDA Link
12/2020 - 01/2018
4Trastuzumab (Herceptin)FDA Link
09/2023 - 01/2021
4pyrotinibIBA
01/2023 - 01/2021
4Hormones (Hormone)IBA
01/2023 - 01/2019
2human ERBB2 proteinIBA
09/2023 - 01/2023
2Biomarkers (Surrogate Marker)IBA
09/2023 - 10/2018
2pertuzumabIBA
09/2023 - 01/2023
216-fluoroestradiolIBA
01/2023 - 09/2021
2Capecitabine (Xeloda)FDA Link
01/2023 - 01/2021
2taxaneIBA
01/2023 - 01/2021
2GemcitabineFDA Link
01/2022 - 01/2019
2130-nm albumin-bound paclitaxelIBA
11/2021 - 01/2019
2EverolimusFDA Link
01/2021 - 01/2020
2Epidermal Growth Factor (EGF)IBA
01/2021 - 01/2019
2Lapatinib (GW572016)FDA Link
01/2021 - 01/2020
2Aromatase InhibitorsIBA
01/2020 - 01/2019
2exemestane (Aromasin)FDA Link
01/2020 - 01/2019
1ChromatinIBA
04/2023
1Proteins (Proteins, Gene)FDA Link
04/2023
1trastuzumab deruxtecanIBA
01/2023
1CopperIBA
01/2023
1Therapeutic UsesIBA
01/2023
1Immunoconjugates (Immunoconjugate)IBA
01/2023
1Oleic Acid (Oleate)IBA
01/2022
1Paclitaxel (Taxol)FDA LinkGeneric
01/2022
1Albumin-Bound PaclitaxelFDA Link
11/2021
1eribulinFDA Link
01/2021
1Vinorelbine (Navelbine)FDA LinkGeneric
01/2021
1Tyrosine Kinase InhibitorsIBA
01/2021
1ErbB Receptors (EGF Receptor)IBA
01/2020
1PlatinumIBA
01/2019
1Cisplatin (Platino)FDA LinkGeneric
01/2019
1Fluorine-18IBA
01/2019
1Reactive Oxygen Species (Oxygen Radicals)IBA
11/2016
1Nonesterified Fatty Acids (NEFA)IBA
11/2016
1Fatty Acids (Saturated Fatty Acids)IBA
11/2016
1Deoxyglucose (2 Deoxy D glucose)IBA
11/2016
1Phospholipids (Phosphatides)FDA LinkGeneric
11/2016
1Adenosine Triphosphate (ATP)IBA
11/2016
1phospholipase D1IBA
11/2016
1Phospholipases (Phospholipase)IBA
11/2016
1Glucose (Dextrose)FDA LinkGeneric
11/2016

Therapy/Procedure

11Therapeutics
09/2023 - 11/2016
10Drug Therapy (Chemotherapy)
01/2023 - 10/2018
1Immunotherapy
01/2022